Ventyx Biosciences Current Cash

The latest current cash for VTYX is $32M as of September 2025. That compares with $62M in the prior-year period — down 48.2% year over year. Investors often review this figure alongside Ventyx Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, VTYX's current cash moved from $62M to $32M — a 48.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ventyx Biosciences's operating scale or balance-sheet position.

A current cash figure of $32M for VTYX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VTYX's current cash ($32M), review year-over-year change from $62M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.